GlycoMimetics Ownership 2024 | Who Owns GlycoMimetics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

3.21%

Insider Ownership

8.86%

Retail Ownership

87.93%

Institutional Holders

9.00

GlycoMimetics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL14.81%0.08%9,544,262--2,687,664Jun 30, 2024
ARTAL GROUP S.A.13.33%0.06%8,589,064--2,418,680Jun 30, 2024
VANGUARD GROUP INC4.18%-2,696,906-65,075-2.36%759,448Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.28%0.00%826,851685,151483.52%232,841Jun 30, 2024
GOLDMAN SACHS GROUP INC1.25%-804,342-310,366-27.84%226,503Jun 30, 2024
BLACKROCK INC.1.12%-723,184-9,383-1.28%203,649Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.1.01%0.00%650,000320,10097.03%183,040Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.83%0.00%534,753204,22761.79%150,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.76%-487,242-17,905-3.54%137,243Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.29%-186,227-560,727-75.07%52,442Jun 30, 2024
STATE STREET CORP0.28%-179,265--50,481,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.21%0.01%135,000-4,100-2.95%38,016Jun 30, 2024
NORTHERN TRUST CORP0.20%-127,792-965-0.75%35,986,000Jun 30, 2024
SARGENT INVESTMENT GROUP, LLC0.16%0.01%100,000-8,000-7.41%28,160Jun 30, 2024
UBS GROUP AG0.13%-83,02081,5205434.67%23,412Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.13%0.00%81,800-86,800-51.48%23,035Jun 30, 2024
TORNO CAPITAL, LLC0.12%0.00%74,70074,700100.00%21,036Jun 30, 2024
GROUP ONE TRADING, L.P.0.10%0.00%65,43336,754128.16%18,426,000Jun 30, 2024
HRT FINANCIAL LP0.07%0.00%47,683-108,147-69.40%13,000Jun 30, 2024
INTELLECTUS PARTNERS, LLC0.07%0.00%45,965-4,755-9.38%12,944Jun 30, 2024

GlycoMimetics's largest institutional shareholder is BVF INC/IL, holding 14.81% of the company's total share outstanding, currently valued at $2.69M. The top 10 institutional shareholders own together 38.85% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL14.81%0.08%9,544,262--2,687,664Jun 30, 2024
ARTAL GROUP S.A.13.33%0.06%8,589,064--2,418,680Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.21%0.01%135,000135,000100.00%38,016Jun 30, 2024
SARGENT INVESTMENT GROUP, LLC0.16%0.01%100,000-8,000-7.41%28,160Jun 30, 2024
INTELLECTUS PARTNERS, LLC0.07%0.00%45,965-4,755-9.38%12,944Jun 30, 2024
TORNO CAPITAL, LLC0.12%0.00%74,70074,700100.00%21,036Jun 30, 2024
TOBIAS FINANCIAL ADVISORS, INC.0.02%0.00%15,000--4,224Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.13%0.00%81,800-86,800-51.48%23,035Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.83%0.00%534,753204,22761.79%150,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.28%0.00%826,851685,151483.52%232,841Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.1.01%0.00%650,000320,10097.03%183,040Jun 30, 2024
LETKO, BROSSEAU & ASSOCIATES INC0.07%0.00%45,250--12,742Jun 30, 2024
IEQ CAPITAL, LLC0.06%0.00%38,363--10,803Jun 30, 2024
HRT FINANCIAL LP0.07%0.00%47,683-108,147-69.40%13,000Jun 30, 2024
GROUP ONE TRADING, L.P.0.10%0.00%65,43336,754128.16%18,426,000Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.01%0.00%4,7554,755100.00%1,032Jun 30, 2024
GOLDMAN SACHS GROUP INC1.25%-804,342-310,366-27.84%226,503Jun 30, 2024
LMR PARTNERS LLP0.02%-14,102--3,971Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.29%-186,227-560,727-75.07%52,442Jun 30, 2024
VANGUARD GROUP INC4.18%-2,696,906-65,075-2.36%759,448Jun 30, 2024

The largest GlycoMimetics shareholder by % of total assets is BVF INC/IL. The company owns 9.54M shares of GlycoMimetics (GLYC), representing 0.08% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC1.28%0.00%826,851685,151483.52%232,841Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.1.01%0.00%650,000320,10097.03%183,040Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.83%0.00%534,753204,22761.79%150,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.21%0.01%135,000135,000100.00%38,016Jun 30, 2024
UBS GROUP AG0.13%-83,02081,5205434.67%23,412Jun 30, 2024
TORNO CAPITAL, LLC0.12%0.00%74,70074,700100.00%21,036Jun 30, 2024
GROUP ONE TRADING, L.P.0.10%0.00%65,43336,754128.16%18,426,000Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.01%0.00%4,7554,755100.00%1,032Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.00%-600600100.00%177Jun 30, 2024
LMR PARTNERS LLP0.00%-500500100.00%141Jun 30, 2024
ROYAL BANK OF CANADA0.00%-2,31931915.95%1,000Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.00%-481--135Jun 30, 2024
RHUMBLINE ADVISERS0.00%-1,044--294Jun 30, 2024
STATE STREET CORP0.28%-179,265--50,481,000Jun 30, 2024
LMR PARTNERS LLP0.02%-14,102--3,971Jun 30, 2024
IEQ CAPITAL, LLC0.06%0.00%38,363--10,803Jun 30, 2024
LETKO, BROSSEAU & ASSOCIATES INC0.07%0.00%45,250--12,742Jun 30, 2024
TOBIAS FINANCIAL ADVISORS, INC.0.02%0.00%15,000--4,224Jun 30, 2024
ARTAL GROUP S.A.13.33%0.06%8,589,064--2,418,680Jun 30, 2024
BVF INC/IL14.81%0.08%9,544,262--2,687,664Jun 30, 2024

As of Jun 30 2024, GlycoMimetics's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 685.15K stocks of GLYC, valued at $232.84K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEA MANAGEMENT COMPANY, LLC----3,835,039-100.00%-Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP----3,000,000-100.00%-Jun 30, 2024
AXA S.A.----1,587,741-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.29%-186,227-560,727-75.07%52,442Jun 30, 2024
GOLDMAN SACHS GROUP INC1.25%-804,342-310,366-27.84%226,503Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-1,101-219,247-99.50%310Jun 30, 2024
MARSHALL WACE, LLP----217,501-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----180,787-100.00%-Jun 30, 2024
IKARIAN CAPITAL, LLC----172,800-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----162,428-100.00%-Jun 30, 2024
MAN GROUP PLC----149,859-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----142,300-100.00%-Jun 30, 2024
HRT FINANCIAL LP0.07%0.00%47,683-108,147-69.40%13,000Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.----100,000-100.00%-Jun 30, 2024
MORGAN STANLEY0.01%-5,176-97,912-94.98%1,457Jun 30, 2024
SIMPLEX TRADING, LLC----90,652-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.13%0.00%81,800-86,800-51.48%23,035Jun 30, 2024
JPMORGAN CHASE & CO0.00%-151-84,473-99.82%43Jun 30, 2024
VANGUARD GROUP INC4.18%-2,696,906-65,075-2.36%759,448Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----63,642-100.00%-Jun 30, 2024

As of Jun 30 2024, GlycoMimetics's biggest institutional seller is NEA MANAGEMENT COMPANY, LLC. The company sold -3.84M shares of GLYC, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAR1 CAPITAL MANAGEMENT, LLC0.21%0.01%135,000135,000100.00%38,016Jun 30, 2024
TORNO CAPITAL, LLC0.12%0.00%74,70074,700100.00%21,036Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.01%0.00%4,7554,755100.00%1,032Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.00%-600600100.00%177Jun 30, 2024
LMR PARTNERS LLP0.00%-500500100.00%141Jun 30, 2024

GlycoMimetics's largest new institutional shareholder by number of shares is ADAR1 CAPITAL MANAGEMENT, LLC, purchased 135.00K shares, valued at $38.02K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEA MANAGEMENT COMPANY, LLC----3,835,039-100.00%-Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP----3,000,000-100.00%-Jun 30, 2024
AXA S.A.----1,587,741-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----217,501-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----180,787-100.00%-Jun 30, 2024
IKARIAN CAPITAL, LLC----172,800-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----162,428-100.00%-Jun 30, 2024
MAN GROUP PLC----149,859-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----142,300-100.00%-Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.----100,000-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----90,652-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----63,642-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----51,868-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----49,798-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----45,600-100.00%-Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD----43,130-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----40,557-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----38,200-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----35,698-100.00%-Jun 30, 2024
OMERS ADMINISTRATION CORP----30,600-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----23,622-100.00%-Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----23,339-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----23,156-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----22,361-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----20,315-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----20,103-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----18,805-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----18,321-100.00%-Jun 30, 2024
CTC ALTERNATIVE STRATEGIES, LTD.----17,700-100.00%-Jun 30, 2024
PINE VALLEY INVESTMENTS LTD LIABILITY CO----12,520-100.00%-Jun 30, 2024
BELVEDERE TRADING LLC----3,600-100.00%-Jun 30, 2024
HARTFORD FINANCIAL MANAGEMENT INC.----3,500-100.00%-Jun 30, 2024
TRUVESTMENTS CAPITAL LLC----2,057-100.00%-Jun 30, 2024
MACQUARIE GROUP LTD----1,939-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----500-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----383-100.00%-Jun 30, 2024
FMR LLC----67-100.00%-Jun 30, 2024

GlycoMimetics's largest sold out institutional shareholder by shares sold is NEA MANAGEMENT COMPANY, LLC, sold -3.84M shares, valued at -, as of undefined.

GlycoMimetics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.11%54,900--Mar 31, 2024
Federated Hermes MDT Series0.09%212,114--Jan 31, 2024
BRIDGEWAY FUNDS INC0.07%163,200-28,600-14.91%Mar 28, 2024
ALGER FUNDS0.06%55,000--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.04%8,547--Mar 28, 2024
ETFis Series Trust I0.04%62,689--Jan 31, 2024
Vericimetry Funds0.04%3,180--Mar 31, 2024
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.03%975,207--Jan 31, 2024
FORUM FUNDS II0.02%24,900--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%78,191--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,874--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%55,407--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%2,655,896-308,115-10.40%Mar 31, 2024
VANGUARD HORIZON FUNDS0.01%146,428--Mar 31, 2024
ALPS ETF Trust0.01%75,579--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,226--Mar 31, 2024
JNL VARIABLE FUND LLC0.01%28,975--Mar 31, 2020
TIAA-CREF LIFE FUNDS0.00%13,141--Mar 31, 2024
Fidelity Commonwealth Trust II0.00%20,861--Aug 31, 2023
Forethought Variable Insurance Trust0.00%11,196--Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%448,40021,0944.94%Feb 29, 2024
Voya PARTNERS INC0.00%173,554--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%61,101--Mar 31, 2024
HARTFORD SERIES FUND INC0.00%56,862--Mar 31, 2024
MASSMUTUAL PREMIER FUNDS0.00%35,564--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%36,873-2,960-7.43%Mar 31, 2024
Calvert Variable Products, Inc.0.00%2,997--Mar 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%78,363--Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%13,281--Jan 31, 2024
SunAmerica Specialty Series0.00%306--Apr 30, 2021
SCHWAB CAPITAL TRUST0.00%22,361--Jan 31, 2024
Principal Exchange-Traded Funds0.00%6,305--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%2,100--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%33,227--Jan 31, 2024
HC CAPITAL TRUST0.00%11,674--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%376,069--Mar 31, 2024
AMG FUNDS III0.00%1,426--Mar 28, 2024
RUSSELL INVESTMENT CO0.00%84,135--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%34,376--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%15,087--Feb 29, 2024
LoCorr Investment Trust0.00%5,507--Mar 31, 2024
TIAA-CREF FUNDS0.00%632,085--Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%6,075--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%19,40616,953691.11%Feb 29, 2024
Meeder Funds0.00%809--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,857--Mar 31, 2024
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%283,790--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,791--Mar 31, 2024
PGIM ETF TRUST0.00%6,400--Feb 29, 2024
PACE SELECT ADVISORS TRUST0.00%26,108--Jan 31, 2024
NORTHERN FUNDS0.00%11,161--Mar 28, 2024
FIDELITY SALEM STREET TRUST0.00%285,755--Mar 31, 2024
ProFunds0.00%804--Mar 31, 2024
VALIC Co I0.00%17,588--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%5,325--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%110,887--Feb 29, 2024
HARTFORD MUTUAL FUNDS INC/CT0.00%404,265--Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,517--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,300--Mar 28, 2024
FINANCIAL INVESTORS TRUST0.00%2,843--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%4,290-1,078-20.08%Jan 31, 2024
Brighthouse Funds Trust II0.00%28,848--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%6,361--Jan 31, 2024
Dimensional ETF Trust0.00%8,890--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,545--Feb 29, 2024
Blackstone Alternative Investment Funds0.00%1,800-1,100-37.93%Mar 31, 2024
VANGUARD WELLINGTON FUND0.00%5,974--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%331--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,952--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%12,930--Jan 31, 2024
Brighthouse Funds Trust I0.00%91,804--Mar 31, 2024
Legg Mason Global Asset Management Trust0.00%90,941--Jan 31, 2024
iShares U.S. ETF Trust0.00%1,013--Jan 31, 2024
EQ ADVISORS TRUST0.00%8,791240.27%Mar 31, 2024
iSHARES TRUST0.00%118,412-34-0.03%Mar 31, 2024
PACIFIC SELECT FUND0.00%22,684--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%4,792--Dec 31, 2023
Bridge Builder Trust0.00%13,520--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%3,789--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,523--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%4,317--Feb 29, 2024
BLACKROCK FUNDS0.00%3,909--Mar 28, 2024
AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS)0.00%7,506--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%933--Mar 31, 2024
John Hancock Funds II0.00%6,083--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%6,500--Feb 29, 2024
VANGUARD WORLD FUND0.00%60--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%22--Jan 31, 2024

GlycoMimetics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 54.90K shares, compromising 0.11% of its total assets.

GlycoMimetics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 249-88.89%
31 Mar, 248132.79%
31 Dec, 236124.49%
30 Sep, 2349-12.50%
30 Jun, 2356-12.50%
31 Mar, 236428.00%
31 Dec, 225072.41%
30 Sep, 2229-9.38%
30 Jun, 2232-20.00%
31 Mar, 2240-18.37%
31 Dec, 2149-2.00%
30 Sep, 2150-18.03%
30 Jun, 2161-21.79%
31 Mar, 2178-15.22%
31 Dec, 209210.84%
30 Sep, 2083-4.60%
30 Jun, 208716.00%
31 Mar, 2075-7.41%
31 Dec, 19816.58%
30 Sep, 1976-6.17%
30 Jun, 1981-1.22%
31 Mar, 19821.23%
31 Dec, 1881-10.99%
30 Sep, 18911.11%
30 Jun, 1890-
31 Mar, 18907.14%
31 Dec, 178442.37%
30 Sep, 1759-16.90%
30 Jun, 177165.12%
31 Mar, 1743-14.00%
31 Dec, 16504.17%
30 Sep, 1648-5.88%
30 Jun, 165175.86%
31 Mar, 16293.57%
31 Dec, 1528-6.67%
30 Sep, 1530-3.23%
30 Jun, 153110.71%
31 Mar, 1528-
31 Dec, 14283.70%
30 Sep, 1427-12.90%
30 Jun, 1431-13.89%
31 Mar, 1436-

As of 30 Jun 24, 9 institutions are holding GlycoMimetics's shares, representing a decrease of -88.89% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 242,070,705-94.38%
31 Mar, 2436,848,9064.98%
31 Dec, 2335,101,6641.11%
30 Sep, 2334,716,628-2.43%
30 Jun, 2335,581,469-3.82%
31 Mar, 2336,994,29634.56%
31 Dec, 2227,492,4736.01%
30 Sep, 2225,934,578-1.95%
30 Jun, 2226,449,775-3.14%
31 Mar, 2227,307,670-7.70%
31 Dec, 2129,585,2750.27%
30 Sep, 2129,506,778-5.13%
30 Jun, 2131,103,120-15.06%
31 Mar, 2136,617,382-5.21%
31 Dec, 2038,631,288-3.16%
30 Sep, 2039,890,497-1.18%
30 Jun, 2040,366,6941.78%
31 Mar, 2039,659,327-4.59%
31 Dec, 1941,566,162-0.22%
30 Sep, 1941,657,947-7.25%
30 Jun, 1944,914,066-1.22%
31 Mar, 1945,469,6650.58%
31 Dec, 1845,207,377-2.52%
30 Sep, 1846,377,1380.10%
30 Jun, 1846,332,3846.09%
31 Mar, 1843,672,24636.94%
31 Dec, 1731,891,4787.19%
30 Sep, 1729,750,957-1.84%
30 Jun, 1730,308,08258.46%
31 Mar, 1719,126,5501.02%
31 Dec, 1618,933,7592.87%
30 Sep, 1618,406,240-0.53%
30 Jun, 1618,503,81031.61%
31 Mar, 1614,059,0541.38%
31 Dec, 1513,867,664-23.31%
30 Sep, 1518,082,57031.35%
30 Jun, 1513,767,0090.16%
31 Mar, 1513,745,019-1.10%
31 Dec, 1413,897,5783.73%
30 Sep, 1413,398,153-0.88%
30 Jun, 1413,517,067-3.93%
31 Mar, 1414,070,230-

GlycoMimetics (GLYC) has 2.07M shares outstanding as of 30 Jun 24, down -94.38% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 243.21%0.10%
31 Mar, 2457.22%1.92%
31 Dec, 2354.55%1.87%
30 Sep, 2354.01%1.55%
30 Jun, 2358.96%1.57%
31 Mar, 2361.30%2.27%
31 Dec, 2251.91%2.12%
30 Sep, 2249.47%1.94%
30 Jun, 2250.47%1.85%
31 Mar, 2252.18%1.58%
31 Dec, 2157.50%1.76%
30 Sep, 2157.22%1.57%
30 Jun, 2160.35%1.16%
31 Mar, 2172.23%1.01%
31 Dec, 2084.49%1.20%
30 Sep, 2083.96%0.99%
30 Jun, 2092.16%1.11%
31 Mar, 2091.01%0.99%
31 Dec, 1996.10%1.04%
30 Sep, 1996.22%0.89%
30 Jun, 19104.01%0.94%
31 Mar, 19105.33%0.96%
31 Dec, 18104.78%0.90%
30 Sep, 18107.68%0.92%
30 Jun, 18108.23%0.70%
31 Mar, 18124.22%1.51%
31 Dec, 1790.71%1.10%
30 Sep, 1790.91%0.73%
30 Jun, 17111.26%1.68%
31 Mar, 1781.46%1.21%
31 Dec, 1681.93%1.28%
30 Sep, 1679.86%0.91%
30 Jun, 1693.49%1.72%
31 Mar, 1673.72%1.39%
31 Dec, 1572.82%0.81%
30 Sep, 1595.04%1.81%
30 Jun, 1572.41%1.38%
31 Mar, 1572.49%1.34%
31 Dec, 1473.52%1.46%
30 Sep, 1470.91%1.37%
30 Jun, 1471.87%1.08%
31 Mar, 1481.65%-

As of 30 Jun 24, GlycoMimetics is held by 3.21% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 243-93.88%
31 Mar, 244981.48%
31 Dec, 2327107.69%
30 Sep, 2313-7.14%
30 Jun, 2314-61.11%
31 Mar, 233633.33%
31 Dec, 2227237.50%
30 Sep, 22814.29%
30 Jun, 227-41.67%
31 Mar, 2212-36.84%
31 Dec, 211926.67%
30 Sep, 2115-37.50%
30 Jun, 2124-22.58%
31 Mar, 2131-40.38%
31 Dec, 205279.31%
30 Sep, 2029-45.28%
30 Jun, 205335.90%
31 Mar, 2039-4.88%
31 Dec, 1941-
30 Sep, 194120.59%
30 Jun, 1934-19.05%
31 Mar, 194213.51%
31 Dec, 1837-15.91%
30 Sep, 1844-18.52%
30 Jun, 1854-10.00%
31 Mar, 18607.14%
31 Dec, 175680.65%
30 Sep, 1731-43.64%
30 Jun, 1755243.75%
31 Mar, 1716-40.74%
31 Dec, 162728.57%
30 Sep, 1621-46.15%
30 Jun, 1639254.55%
31 Mar, 1611-21.43%
31 Dec, 151416.67%
30 Sep, 1512-33.33%
30 Jun, 151812.50%
31 Mar, 151623.08%
31 Dec, 141330.00%
30 Sep, 1410-44.44%
30 Jun, 1418-50.00%
31 Mar, 1436-

3 institutional shareholders have increased their position in GLYC stock as of 30 Jun 24 compared to 49 in the previous quarter (a -93.88% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 244-55.56%
31 Mar, 249-35.71%
31 Dec, 2314-22.22%
30 Sep, 2318-5.26%
30 Jun, 231990.00%
31 Mar, 2310-23.08%
31 Dec, 2213116.67%
30 Sep, 226-53.85%
30 Jun, 2213-23.53%
31 Mar, 221713.33%
31 Dec, 2115-25.00%
30 Sep, 2120-9.09%
30 Jun, 2122-12.00%
31 Mar, 212525.00%
31 Dec, 2020-37.50%
30 Sep, 203239.13%
30 Jun, 2023-8.00%
31 Mar, 2025-7.41%
31 Dec, 192742.11%
30 Sep, 1919-42.42%
30 Jun, 193350.00%
31 Mar, 1922-15.38%
31 Dec, 18268.33%
30 Sep, 18244.35%
30 Jun, 182335.29%
31 Mar, 1817-15.00%
31 Dec, 172025.00%
30 Sep, 171645.45%
30 Jun, 1711-8.33%
31 Mar, 171250.00%
31 Dec, 168-46.67%
30 Sep, 1615200.00%
30 Jun, 165-37.50%
31 Mar, 16860.00%
31 Dec, 155-50.00%
30 Sep, 1510150.00%
30 Jun, 154-
31 Mar, 154-33.33%
31 Dec, 146-40.00%
30 Sep, 141011.11%
30 Jun, 149-
31 Mar, 14--

4 institutional shareholders have reduced their position in GLYC stock as of 30 Jun 24 compared to 9 in the previous quarter (a -55.56% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 249-88.89%2,070,705-94.38%3.21%0.10%3-93.88%4-55.56%
31 Mar, 248132.79%36,848,9064.98%57.22%1.92%4981.48%9-35.71%
31 Dec, 236124.49%35,101,6641.11%54.55%1.87%27107.69%14-22.22%
30 Sep, 2349-12.50%34,716,628-2.43%54.01%1.55%13-7.14%18-5.26%
30 Jun, 2356-12.50%35,581,469-3.82%58.96%1.57%14-61.11%1990.00%
31 Mar, 236428.00%36,994,29634.56%61.30%2.27%3633.33%10-23.08%
31 Dec, 225072.41%27,492,4736.01%51.91%2.12%27237.50%13116.67%
30 Sep, 2229-9.38%25,934,578-1.95%49.47%1.94%814.29%6-53.85%
30 Jun, 2232-20.00%26,449,775-3.14%50.47%1.85%7-41.67%13-23.53%
31 Mar, 2240-18.37%27,307,670-7.70%52.18%1.58%12-36.84%1713.33%
31 Dec, 2149-2.00%29,585,2750.27%57.50%1.76%1926.67%15-25.00%
30 Sep, 2150-18.03%29,506,778-5.13%57.22%1.57%15-37.50%20-9.09%
30 Jun, 2161-21.79%31,103,120-15.06%60.35%1.16%24-22.58%22-12.00%
31 Mar, 2178-15.22%36,617,382-5.21%72.23%1.01%31-40.38%2525.00%
31 Dec, 209210.84%38,631,288-3.16%84.49%1.20%5279.31%20-37.50%
30 Sep, 2083-4.60%39,890,497-1.18%83.96%0.99%29-45.28%3239.13%
30 Jun, 208716.00%40,366,6941.78%92.16%1.11%5335.90%23-8.00%
31 Mar, 2075-7.41%39,659,327-4.59%91.01%0.99%39-4.88%25-7.41%
31 Dec, 19816.58%41,566,162-0.22%96.10%1.04%41-2742.11%
30 Sep, 1976-6.17%41,657,947-7.25%96.22%0.89%4120.59%19-42.42%
30 Jun, 1981-1.22%44,914,066-1.22%104.01%0.94%34-19.05%3350.00%
31 Mar, 19821.23%45,469,6650.58%105.33%0.96%4213.51%22-15.38%
31 Dec, 1881-10.99%45,207,377-2.52%104.78%0.90%37-15.91%268.33%
30 Sep, 18911.11%46,377,1380.10%107.68%0.92%44-18.52%244.35%
30 Jun, 1890-46,332,3846.09%108.23%0.70%54-10.00%2335.29%
31 Mar, 18907.14%43,672,24636.94%124.22%1.51%607.14%17-15.00%
31 Dec, 178442.37%31,891,4787.19%90.71%1.10%5680.65%2025.00%
30 Sep, 1759-16.90%29,750,957-1.84%90.91%0.73%31-43.64%1645.45%
30 Jun, 177165.12%30,308,08258.46%111.26%1.68%55243.75%11-8.33%
31 Mar, 1743-14.00%19,126,5501.02%81.46%1.21%16-40.74%1250.00%
31 Dec, 16504.17%18,933,7592.87%81.93%1.28%2728.57%8-46.67%
30 Sep, 1648-5.88%18,406,240-0.53%79.86%0.91%21-46.15%15200.00%
30 Jun, 165175.86%18,503,81031.61%93.49%1.72%39254.55%5-37.50%
31 Mar, 16293.57%14,059,0541.38%73.72%1.39%11-21.43%860.00%
31 Dec, 1528-6.67%13,867,664-23.31%72.82%0.81%1416.67%5-50.00%
30 Sep, 1530-3.23%18,082,57031.35%95.04%1.81%12-33.33%10150.00%
30 Jun, 153110.71%13,767,0090.16%72.41%1.38%1812.50%4-
31 Mar, 1528-13,745,019-1.10%72.49%1.34%1623.08%4-33.33%
31 Dec, 14283.70%13,897,5783.73%73.52%1.46%1330.00%6-40.00%
30 Sep, 1427-12.90%13,398,153-0.88%70.91%1.37%10-44.44%1011.11%
30 Jun, 1431-13.89%13,517,067-3.93%71.87%1.08%18-50.00%9-
31 Mar, 1436-14,070,230-81.65%-36---

GlycoMimetics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell61,488$0.18$11.20K6,578,438
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell260,873$0.19$50.01K6,317,565
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell164,523$0.19$31.00K6,695,658
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell55,732$0.18$10.19K6,639,926
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell63,564$0.22$13.74K7,146,381
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell286,200$0.20$57.35K6,860,181
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell258,335$0.24$62.44K8,330,729
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell363,949$0.24$85.64K7,966,780
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell756,835$0.22$167.18K7,209,945
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy115,000$0.27$30.72K680,403
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy190,000$0.25$48.11K565,403
Jun 20, 2024Hahn Brian M.officer SVP Finance, CFOP-PurchaseBuy17,500$0.25$4.33K70,643

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy115,000$0.27$30.72K680,403
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy190,000$0.25$48.11K565,403
Jun 20, 2024Hahn Brian M.officer SVP Finance, CFOP-PurchaseBuy17,500$0.25$4.33K70,643

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell61,488$0.18$11.20K6,578,438
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell260,873$0.19$50.01K6,317,565
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell164,523$0.19$31.00K6,695,658
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell55,732$0.18$10.19K6,639,926
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell63,564$0.22$13.74K7,146,381
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell286,200$0.20$57.35K6,860,181
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell258,335$0.24$62.44K8,330,729
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell363,949$0.24$85.64K7,966,780
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell756,835$0.22$167.18K7,209,945
Jul 29, 2024Siren, L.L.C.10 percent owner-Sell---8,589,064

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell61,488$0.18$11.20K6,578,438
Aug 09, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell260,873$0.19$50.01K6,317,565
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell164,523$0.19$31.00K6,695,658
Aug 07, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell55,732$0.18$10.19K6,639,926
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell63,564$0.22$13.74K7,146,381
Aug 05, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell286,200$0.20$57.35K6,860,181
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell258,335$0.24$62.44K8,330,729
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell363,949$0.24$85.64K7,966,780
Jul 30, 2024Invus Public Equities, L.P.10 percent owner-S-SaleSell756,835$0.22$167.18K7,209,945
Jul 29, 2024Siren, L.L.C.10 percent owner-Sell---8,589,064
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy115,000$0.27$30.72K680,403
Jun 24, 2024Rock Edwinofficer Chief Medical OfficerP-PurchaseBuy190,000$0.25$48.11K565,403
Jun 20, 2024Hahn Brian M.officer SVP Finance, CFOP-PurchaseBuy17,500$0.25$4.33K70,643
May 01, 2024Koenig Scottdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Goldberg Mark Alandirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024PEARSON TIMOTHY Rdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024King Rachel K.director-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Andrews Patricia Sdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Jackson Scott Thomasdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024JUNIUS DANIEL Mdirector-A-AwardBuy40,000$1.62$64.80K40,000

The last insider sell of GlycoMimetics's stock was made by Invus Public Equities, L.P. on Aug 09 2024, selling 61,488 shares at $0.18 per share (valued at $11.20K). The last insider buy of GLYC was made by Rock Edwin on Jun 24 2024, buying 115,000 shares at $0.27 per share (worth $30.72K).

GlycoMimetics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-10-
Q2 202410--
Q1 20248--
Q4 20233--
Q3 20235--
Q2 2023102500.00%
Q1 2023121770.59%
Q4 202292450.00%
Q3 202211100.00%
Q2 202213--
Q1 202273233.33%
Q4 20211--
Q3 2021-2-
Q2 202112--
Q1 2021105200.00%
Q4 202083266.67%
Q2 20206--
Q1 202071700.00%
Q4 201911100.00%
Q3 201954125.00%

0 total buy trades, and 10 total sell trades (buy/sell ratio of 0.00%) were made by GlycoMimetics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-9-
Q2 20243--
Q1 2024---
Q4 2023---
Q3 20232--
Q2 202321200.00%
Q1 202381080.00%
Q4 202292450.00%
Q3 2022---
Q2 2022---
Q1 2022-3-
Q4 20211--
Q3 2021---
Q2 2021---
Q1 2021---
Q4 202061600.00%
Q2 2020---
Q1 20201--
Q4 2019---
Q3 20194--

As of Q3 2024, Insider owners conducted 0 open market buy trades and 9 open market sell trades of GlycoMimetics's stocks.

GlycoMimetics Peer Ownership


TickerCompany
CUECue Biopharma, Inc.
DYNDyne Therapeutics, Inc.
ACHLAchilles Therapeutics plc
IVAInventiva S.A.
BCABBioAtla, Inc.
FHTXFoghorn Therapeutics Inc.
MLYSMineralys Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
ASMBAssembly Biosciences, Inc.
TRVITrevi Therapeutics, Inc.
NLTXNeurogene Inc.
LIFEaTyr Pharma, Inc.
TILInstil Bio, Inc.

GLYC Ownership FAQ


GlycoMimetics is owned by institutional shareholders (3.21%), insiders (8.86%), and public (87.93%). The largest institutional shareholder of GlycoMimetics is BVF INC/IL (14.81% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).

GlycoMimetics's major institutional shareholders are BVF INC/IL, ARTAL GROUP S.A., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and GOLDMAN SACHS GROUP INC. The top five shareholders own together 34.85% of the company's share outstanding.

As of Jun 2024, there are 9 institutional shareholders of GlycoMimetics.

BVF INC/IL owns 9.54M shares of GlycoMimetics, representing 14.81% of the company's total shares outstanding, valued at $2.69M (as of Jun 2024).

As of Jun 2024, ARTAL GROUP S.A holds 8.59M shares of GlycoMimetics (GLYC), compromising 13.33% of the company, valued at $2.42M.

VANGUARD GROUP INC is the third largest holder of GlycoMimetics. The company owns 2.7M of the company's shares outstanding (worth $759.45K).